Skip to search formSkip to main contentSkip to account menu

Edivoxetine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
The aim of this study is to gather evidence of head-to-head double-blind randomized-controlled trials on the efficacy and safety… 
2016
2016
OBJECTIVE Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as… 
Highly Cited
2015
Highly Cited
2015
In this study we demonstrate that molecular fragments, which can be readily coupled via a simple, in situ RO-C═OR bond-forming… 
2015
2015
Norepinephrine, a neurotransmitter in the autonomic sympathetic nervous system, is deaminated by monoamine oxidase to 3,4… 
Review
2015
Review
2015
Abstract Long-term safety, tolerability, and efficacy of adjunctive edivoxetine hydrochloride (hereafter edivoxetine), a highly… 
2014
2014
OBJECTIVE The purpose of this study was to assess the efficacy and safety of edivoxetine (LY2216684), a selective norepinephrine… 
2014
2014
The catechol-O-methyltransferase (COMT) enzyme is responsible for degradation of catecholamines, such as dopamine (DA) and… 
2013
2013
OBJECTIVE The purpose of this study was to assess the clinical outcomes from an open label study of edivoxetine, a selective… 
Review
2013
Review
2013
There are several investigational drugs in development for the treatment of depression. Some of the novel antidepressants in… 
2012
2012
OBJECTIVE Edivoxetine (LY2216684) is a selective and potent norepinephrine reuptake inhibitor (NERI). The pharmacokinetics (PK…